cagrilintide 2.5mg+Semaglutide2.5mg

A dual incretin-based peptide combination designed to support appetite suppression and metabolic control. This blend works by enhancing satiety signals and reducing food intake, helping promote gradual and sustained weight management along with improved metabolic balance.

cagrilintide 2.5mg+Semaglutide2.5mg is a research peptide used in laboratory studies. Research use only. Not for human consumption. 21+.